Citation Impact
Citing Papers
A comparison of recombinant Hirudin with Heparin for the treatment of acute coronary syndromes. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb Investigators
1996
College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: the clinical use and laboratory monitoring of low-molecular-weight heparin, danaparoid, hirudin and related compounds, and argatroban.
1998
Parenteral Anticoagulants
2008
Parenteral Anticoagulants
2012 Standout
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2007
Manipulation of cell surface macromolecules by flaviviruses
2003
Mechanisms of Thrombus Formation
2008 Standout
Bleeding during Thrombolytic Therapy for Acute Myocardial Infarction: Mechanisms and Management
1989
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
2001 Standout
Prospects for Cardiovascular Research
2001 StandoutNobel
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
Bivalirudin during Primary PCI in Acute Myocardial Infarction
2008 Standout
Subcutaneous Low-Molecular-Weight Heparin Compared with Continuous Intravenous Heparin in the Treatment of Proximal-Vein Thrombosis
1992 Standout
Temporal Aspects of Heparin-Induced Thrombocytopenia
2001 Standout
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
2009 Standout
Prolonged Enoxaparin Therapy to Prevent Venous Thromboembolism After Primary Hip or Knee Replacement
2001
Platelets in atherothrombosis
2002
Platelet Activation and Atherothrombosis
2007 Standout
Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery
1993
Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: Study design and rationale
2004
Thrombolysis in myocardial infarction (TIMI) trial—Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase
1988
Intrinsic Immunity Shapes Viral Resistance of Stem Cells
2017 StandoutNobel
Immune Thrombocytopenic Purpura
2002 Standout
Heparin-Induced Thrombocytopenia
2006 Standout
Duration of Prophylaxis against Venous Thromboembolism with Enoxaparin after Surgery for Cancer
2002 Standout
The effect of molecular weight on heparin binding to platelets
1990
Heparin and Low-Molecular-Weight Heparin
1998
Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer
2003 Standout
Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin
1995 Standout
Initiation of Platelet Adhesion by Arrest onto Fibrinogen or Translocation on von Willebrand Factor
1996 Standout
Guidelines for Percutaneous Coronary Interventions
2005
Predictors and Impact of Major Hemorrhage on Mortality Following Percutaneous Coronary Intervention from the REPLACE-2 Trial
2007
Evidence for Prevention of Death and Myocardial Infarction With Platelet Membrane Glycoprotein IIb/IIIa Receptor Blockade by Abciximab (c7E3 Fab) Among Patients With Unstable Angina Undergoing Percutaneous Coronary Revascularization fn1fn1This study was supported by Centocor, Inc., Malvern, Pennsylvania.
1997
Pharmacological and clinical profile of bivalirudin in the treatment of patients with acute coronary syndrome
2009
Atherosclerosis — An Inflammatory Disease
1999 Standout
Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease
2009 Standout
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
2008 Standout
Current issues in reperfusion therapy
1998
A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease
1997 Standout
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade Compared With Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Intervention
2003
A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients
1999 Standout
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Pharmacotherapeutic Aspects of Unfractionated and Low Molecular Weight Heparins
1990
Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag
2012 StandoutNobel
New antithrombotic agents
1999
Advances in Coronary Angioplasty
1996
Antibodies to von Willebrand Factor–Cleaving Protease in Acute Thrombotic Thrombocytopenic Purpura
1998 Standout
New Antithrombotic Agents
1998
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
2007 Standout
Impact of the patient population on the risk for heparin-induced thrombocytopenia
2000 Standout
Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary Syndromes
1998 Standout
A Comparison of Aspirin plus Tirofiban with Aspirin plus Heparin for Unstable Angina
1998
BIOCHEMISTRY AND GENETICS OF VON WILLEBRAND FACTOR
1998 Standout
Production of a fibrinolytic inhibitor by cultured endothelial cells derived from human umbilical vein
1978
SYNTHESIS OF FIBRONECTIN BY CULTURED HUMAN ENDOTHELIAL CELLS
1978
Dynamic monitoring of platelet deposition on severely damaged vessel wall in flowing blood. Effects of different stenoses on thrombus growth.
1990
Platelets and shear stress
1996
Extracellular matrix of cultured bovine aortic endothelial cells contains functionally active type 1 plasminogen activator inhibitor
1987
A New Role for P-Selectin in Shear-Induced Platelet Aggregation
2000
Regulation of endothelial cell DNA synthesis and adherence
1981
Inhibition of Endothelial Regeneration by Type-Beta Transforming Growth Factor from Platelets
1986 StandoutScience
Mammalian reticulocytes lose adhesion to fibronectin during maturation to erythrocytes.
1985 StandoutNobel
Recent advances in molecular pathology
1984
Anticoagulation Monitoring during Cardiac Surgery
1999
Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation
2001 Standout
Fibronectin: A review of its structure and biological activity
1980
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Altered Vascular Injury Responses in Mice Deficient in Protease-Activated Receptor-1
1999
FcγRIIA H/R131 Polymorphism, Subclass-Specific IgG Anti-Heparin/Platelet Factor 4 Antibodies and Clinical Course in Patients With Heparin-Induced Thrombocytopenia and Thrombosis
1997
Monitoring the effect of heparin by measurement of activated clotting time during and after percutaneous transluminal coronary angioplasty.
1990
Low molecular weight heparin
1992
Guide to anticoagulant therapy. Part 1: Heparin. American Heart Association.
1994
Comparison of the Non-Specific Binding of Unfractionated Heparin and Low Molecular Weight Heparin (Enoxaparin) to Plasma Proteins
1993
Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels
1982 Standout
Site-specific chemical modification of recombinant proteins produced in mammalian cells by using the genetically encoded aldehyde tag
2009 StandoutNobel
Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary Revascularization
1997 Standout
Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4
1994
Adhesion of Activated Platelets to Endothelial Cells: Evidence for a GPIIbIIIa-dependent Bridging Mechanism and Novel Roles for Endothelial Intercellular Adhesion Molecule 1 (ICAM-1), αvβ3 Integrin, and GPIbα
1998
Role of Prostacyclin in the Cardiovascular Response to Thromboxane A 2
2002 StandoutScience
Interaction of single-chain urokinase-type plasminogen activator with human endothelial cells.
1990 StandoutNobel
A Comparison of Recombinant Hirudin with Heparin for the Treatment of Acute Coronary Syndromes
1996
Analysis of the Structure and Function of the von Willebrand Factor A1 Domain Using Targeted Deletions and Alanine-Scanning Mutagenesis
1996
Acute Profound Thrombocytopenia After c7E3 Fab (Abciximab) Therapy
1997
Ex-Vivo and In-Vitro Evidence that Low Molecular Weight Heparins Exhibit Less Binding to Plasma Proteins than Unfractionated Heparin
1994
Interpreting the International Normalized Ratio (INR) in Individuals Receiving Argatroban and Warfarin
2001
Generation of Anti-Hirudin Antibodies in Heparin-Induced Thrombocytopenic Patients Treated With R-Hirudin
1999
A unique, pepsin-sensitive collagen synthesized by aortic endothelial cells in culture
1980
COAGULATION DISORDERS IN CANCER
1996
Beyond Unfractionated Heparin and Warfarin
2007
Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues
1997 StandoutScience
Low-Molecular-Weight Heparins
1997 Standout
Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.
1987 Standout
Donor origin of the in vitro haematopoietic microenvironment after marrow transplantation in man
1982 Nature
Synthesis of fibronectin by cultured human endothelial cells.
1978
The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study
2003
Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty
1994 Standout
Free Radicals in the Physiological Control of Cell Function
2002 Standout
Lewis A. Conner Memorial Lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology.
1994
The Myth of the Myocardial ‘Infarctlet’ During Percutaneous Coronary Revascularization Procedures
1996
Weekend versus Weekday Admission and Mortality from Myocardial Infarction
2007 Standout
The Pathogenesis of Atherosclerosis — An Update
1986 Standout
The molecular immunology of human platelet proteins
1992
Oral Delivery of Anticoagulant Doses of Heparin
1998
Low molecular weight heparin
1992
Collagen synthesis by bovine aortic endothelial cells in culture
1979
Vessel injury, platelet adherence, and platelet survival.
1983
Role of collagenous matrices in the adhesion and growth of cells.
1981 Standout
Works of Burt Adelman being referenced
Treatment with Bivalirudin (Hirulog) as Compared with Heparin during Coronary Angioplasty for Unstable or Postinfarction Angina
1995
Anticoagulant effects of hirulog, ∗∗Hirulog™ brand direct thrombin inhibitor. a novel thrombin inhibitor, in patients with coronary artery disease
1993
Characterization of platelet binding of heparins and other glycosaminoglycans
1988
Effect of direct thrombin inhibition with Bivalirudin (Hirulog) on restenosis after coronary angioplasty
1998
Heparin inhibition of von Willebrand factor-dependent platelet function in vitro and in vivo.
1991
Identification and isolation of a platelet GPIb-like protein in human umbilical vein endothelial cells and bovine aortic smooth muscle cells.
1988
Heparin-associated Thrombocytopenia: A Critical Review and Pooled Analysis
1993
Randomized, Double-blind Comparison of Hirulog Versus Heparin in Patients Receiving Streptokinase and Aspirin for Acute Myocardial Infarction (HERO)
1997
In Vivo Imaging and Evaluation of Platelet Accumulation vs. Time at Arterial Injury Site
1985
Percutaneous transluminal coronary angioplasty for unstable angina: Predictors of outcome in a multicenter study
1994
Aurintricarboxylic Acid Prevents Acute Rethrombosis in a Canine Model of Arterial Thrombosis
1995
A pilot, early angiographic patency study using a direct thrombin inhibitor as adjunctive therapy to streptokinase in acute myocardial infarction.
1994
Interaction of platelets and fibrin with injured rabbit aortic neointima. Effect of prostaglandin I2 and heparin.
1983
Plasmin inhibition of platelet function and of arachidonic acid metabolism.
1985
Aurintricarboxylic acid in a canine model of coronary artery thrombosis.
1990
Synthesis of basement membrane collagen by cultured human endothelial cells.
1976
Heparin-associated thrombocytopenia: observations on the mechanism of platelet aggregation.
1989
Length of Hospital Stay and Complications After Percutaneous Transluminal Coronary Angioplasty
1995
Analysis of shear stress and hemodynamic factors in a model of coronary artery stenosis and thrombosis
1993